The Top 5 Analyst Questions From Revvity’s Q1 Earnings Call
Revvity Inc RVTY
$96.38
▲ +1.44%
(+$1.37)
Index member:
S&P 500
Open
$95.70
Prev Close
$95.01
Day Range
$94.89 – $97.97
52W Range
$81.22 – $118.30
Market Cap
$11.10B
P/E (TTM)
45.09
Beta
1.07
Div Yield
0.29%
EPS (TTM)
$2.10
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1965-07-06 |
| Shares Out. | 111,800,000 |
| Website | revvity.com/ ↗ |
| Phone | 17816636900 |
Revvity Inc is a publicly traded company under the ticker symbol RVTY on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
25 analysts (2026-05-01)
📰 Latest News for RVTY
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay
Revvity, Inc. (RVTY) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Revvity, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 09
Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution
3 Cash-Producing Stocks That Concern Us
Is Revvity’s (RVTY) China Exit and EPS Reset Quietly Rewriting Its Portfolio Strategy?
Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $105